Percutaneous Transluminal Coronary Angioplasty (PTCA) Products: Market Research Report

Date: September 22, 2011
Pages: 391
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P5F49F66223EN
Leaflet:

Download PDF Leaflet

Percutaneous Transluminal Coronary Angioplasty (PTCA) Products: Market Research Report
This report analyzes the worldwide markets for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in US$ Million by the following product types: Balloon Catheters, Guiding Catheters, and Guide Wires.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

A six-year historic analysis is also provided for these markets.

The report profiles 34 companies including many key and niche players such as Abbott Vascular, C. R. Bard, Inc., Cordis Corporation, Goodman Co., Ltd., Medtronic, Inc., and Terumo Corporation.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Angioplasty
PTCA Devices
PTCA Balloon Catheter
PTCA Guide Wires
PTCA Guiding Catheters

2.INDUSTRY OVERVIEW

Market Primer
Current & Future Analysis
Recession Decelerates Growth in PTCA Products Market
Rising Incidence and Prevalence of CHD – A Major Growth Driver
Complexity of Older Angioplasty Procedures Drive the Development of Sophisticated Angioplasty Devices
Vagaries Exist Among Adoption of Revascularization Procedures Worldwide

Table 1. Global Angioplasty Procedural Volume (2009-2012): Number of Procedures in Thousands for US, Japan and Rest of World (includes corresponding Graph/Chart)

Angioplasty versus CABG – The Debate on the Most Effective Procedure Continues
Drug-Eluting Balloons (DEBs) – A New Advancement in Intravascular Procedures
Few Products on the Market, Many More to Come
Select Marketed and Development-Stage Drug-Eluting Balloon Products
Expanded Applications to Fortify Demand for Drug Eluting Balloons
Peripheral Arterial Disease Augurs More Prospects for Drug-Eluting Balloons
Promise of Major Benefits Draws Widespread Interest
Drug-Eluting Balloons – A Threat to Drug-Eluting Stents in Coronary Procedures?
Safety Concerns on Drug-Eluting Stents Open Window of Opportunity for Drug-Eluting Balloons
Paclitaxel Remains the Most Sought-After Drug for DEBs

3.COMPETITIVE LANDSCAPE

Boston Scientific Corp. – A Leading Global Player in the Angioplasty Market
Bard Fortifies Market Share, Eyes No. 1 Spot in Peripheral PTA Market

4.STENTING

Stent – A Key Support Device in Angioplasty
Concerns over Restenosis Post-Angioplasty Drives Use of Stents
Stents – Types and Application
A Peek into Peripheral Vascular Stents Market
Lack of Awareness Limits Growth

Table 2. Global Peripheral Vascular Stents Market by Region: Percentage Breakdown of Revenues for US, Europe and Asia-Pacific (includes corresponding Graph/Chart)

Coronary Stents Market – An Overview
Aging Population, New Technologies to Boost Market for Coronary Stents

Table 3. Global Coronary Stents Market by Region: Percentage Breakdown of Revenues for Europe, US, Asia-Pacific and Rest of World (includes corresponding Graph/Chart)

A Brief Insight into the Drug Eluting Stents Market

Table 4. Global Drug-Eluting Stents Market by Product Type (2010): Percentage Breakdown of Unit Sales and Revenues for Coronary Stents and Others (includes corresponding Graph/Chart)

Concerns Over Safety and Cost Restrain Adoption of DES
Intensifying Competition in the DES Space

Table 5. Global Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Abbott Laboratories, Boston Scientific, Medtronic, Johnson & Johnson and Others (includes corresponding Graph/Chart)

5.PRODUCT OVERVIEW

Introduction
What Can Angioplasty Do?
An Overview of Angioplasty Procedure
Types of Angioplasty Procedures
Balloon Angioplasty
Advantages of Angioplasty
Major Disadvantages
Stenting
Laser Angioplasty
Atherectomy
Cutting Balloon
Limitations of the Angioplasty Procedure
Risk Factors in Angioplasty Procedures
Balloon Angioplasty Devices
Balloon Catheters
Guide Wires
Guiding Catheters

6.PRODUCT INNOVATIONS/INTRODUCTIONS

Boston Scientific to Launch Mustang PTA Balloon Catheter
Eurocor Introduces New PTA Balloon Technology
Boston Scientific Introduces Sterling SL Balloon Catheter for Treating PAD
Boston Scientific Rolls out Journey Guidewire for Peripheral Angioplasty Procedures
Volcano to Launch Three Products in the US
TRT and NovaRay Medical Develop X-Ray Imaging System with Nethra's MPPA Devices
Abbott Introduces Omnilink® Elite Peripheral Stent System
Invatec Launches FiberNet®
Cook Medical Launches Zilver PTX Drug-Eluting Peripheral Stent
Abbott Unveils FoxCross™ PTA Catheter and HI-TORQUE Versacore™ Guide Wire
Invatec Unveils Tapered and Amphirion Balloons
Abbott Introduces VOYAGER™ NC Coronary Dilatation Catheter
Vascumed Introduces DIOR Paclitaxel-Coated Coronary Balloon Dilatation Catheter
Invatec Introduces IN.PACT Amphirion Paclitaxel-eluting PTA Balloon Catheter
Cook Medical Introduces New Products for PAD Treatment
Terumo Introduces Glidewire Advantage™ Peripheral Guide Wire
Cook Medical Unveils Advance PTX Balloon
Medtronic Launches Angioplasty Products on Rapid Exchange Delivery System
Cordis Launches SLEEK™ and SAVVY® Long PTA Balloon Dilatation Catheters
B. Braun Introduces SeQuent Please in Malaysia
Cook Medical Rolls Out Advance® 18LP PTA Balloon Dilatation Catheter in North America
Invatec Releases REEF HP™ PTA Balloon Catheter in Europe

7.RECENT INDUSTRY ACTIVITY

FDA Rejects Angioplasty Test of Nanosphere
Terumo Corporation Signs Supply Agreement with Kaneka Subsidiary
Asahi Intecc and Terumo Join Hands to Develop Medical Guidewire
Hotspur Secures FDA Approval for its First Three Commercial Products
Angioslide Secures FDA Clearance for eXtra Angioplasty Balloon Catheter
Opto Circuits Receives European Approval for Marketing Drug Eluting Stent
Volcano Enters into Distribution Agreement with AngioScore
Volcano Acquires Xtract™ Thrombus Range from Lumen Biomedical
Boston Scientific Obtains FDA Approval for NC Quantum Apex Balloon Catheter
Medtronic Acquires Invatec and Associated Companies
Avinger Merges with Sawtooth Labs
Medrad and B Braun Sign Co-Marketing and Trademark License Agreement
Invatec and Cardiovascular Systems Sign Strategic Distribution Agreement
ClearStream Obtains Approval for Marketing Peripheral Angioplasty Balloon
AngioScore Receives Approval for AngioSculpt in Japan
Minnow Medical Obtains Approval for Disposable Catheter
MAQUET’ MEGA™ Intra-Aortic Balloon Catheter Receives CE Mark
FDA Grants Clearance to Cook’s Advance® 35LP PTA Balloon Dilation Catheter
Invatec Obtains CE Mark for IN.PACT™ Admiral Drug Eluting Balloon Catheter
Invatec Receives CE Mark for IN.PACT Falcon Paclitaxel-Eluting PTCA Balloon Catheter

8.FOCUS ON SELECT GLOBAL PLAYERS

Abbott Vascular (US)
Boston Scientific Corporation (US)
C. R. Bard, Inc. (US)
Cordis Corporation (US)
Goodman Co., Ltd. (Japan)
Medtronic, Inc. (US)
Terumo Corporation (Japan)

9.GLOBAL MARKET PERSPECTIVE

Table 6. World Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7. World Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 8. World 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
Table 9. World Recent Past, Current, and Future Analysis for PTCA Balloon Catheters by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 10. World Historic Review for PTCA Balloon Catheters by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 11. World 15-Year Perspective for PTCA Balloon Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
Table 12. World Recent Past, Current, and Future Analysis for PTCA Guiding Catheters by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13. World Historic Review for PTCA Guiding Catheters by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14. World 15-Year Perspective for PTCA Guiding Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
Table 15. World Recent Past, Current, and Future Analysis for PTCA Guide Wires by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 16. World Historic Review for PTCA Guide Wires by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 17. World 15-Year Perspective for PTCA Guide Wires by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

10.THE UNITED STATES

A. MARKET ANALYSIS

Coronary Heart Disease – A Leading Cause of Mortality in the US
Angioplasty – The Most Opted Procedure for Treating CHD in the US

Table 18. US Angioplasty Procedural Volume in Thousands: 2009-2012 (includes corresponding Graph/Chart)

Angioplasty – More Beneficial in Acute Cases
Peripheral Interventional Market Trails High Growth
FDA Reclassifies PTCA Device Status and Drafts Guidance
Market Snippets

Table 19. US Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Boston Scientific, Abbott Laboratories, Medtronic, and Johnson & Johnson (includes corresponding Graph/Chart)

Product Launches
Strategic Corporate Developments
Focus on Select Key Players

B. MARKET ANALYTICS

Table 20. The US Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 21. The US Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 22. The US 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

11.CANADA

A. MARKET ANALYSIS

Angioplasty Procedural Volume Rises in Canada
Improved Access to Angioplasty Centers in Canada
Angioplasty Procedural Costs in Canada – A Recent Past Review

Table 23. Snowballing Effect of Cost Factors on Angioplasty Hospital Costs in Canada: 2005–2006 (includes corresponding Graph/Chart)

Voices Against Extensive Use of Angioplasty Echo in Canada

B. MARKET ANALYTICS

Table 24. Canadian Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 25. Canadian Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 26. Canadian 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

12.JAPAN

A. MARKET ANALYSIS

Government’s Efforts to Curb Prices of IC Devices
Simplified Regulations and Indication Specific Approvals Bring Pace in Peripheral Vascular Stent Market
Competitive Landscape
Terumo Leads Japanese PTCA Balloon Catheter Market
Competition in Japanese Drug-Eluting Stents Market

Table 27. Japanese Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Abbott Laboratories, Boston Scientific, Medtronic, Johnson & Johnson and Others (includes corresponding Graph/Chart)

Product Launch
Strategic Corporate Developments
Focus on Select Key Players

B. MARKET ANALYTICS

Table 28. Japanese Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 29. Japanese Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 30. Japanese 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13.EUROPE

A. MARKET ANALYSIS

CHD In Europe – An Overview on Disease Statistics
Demographic Factors Boost Market Growth
Inconsistency in Drug-Eluting Balloon Approval Procedure Beleaguers Manufacturers
Product Launches
Strategic Corporate Developments

B. MARKET ANALYTICS

Table 31. European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 32. European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 33. European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
Table 34. European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 35. European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 36. European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13A.FRANCE

Market Analysis

Table 37. French Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 38. French Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 39. French 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13B.GERMANY

A. MARKET ANALYSIS

Product Launch
Strategic Corporate Development

B. MARKET ANALYTICS

Table 40. German Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 41. German Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 42. German 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products y Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13C.ITALY

Market Analysis

Table 43. Italian Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 44. Italian Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 45. Italian 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13D.THE UNITED KINGDOM

A. MARKET ANALYSIS

Increasing Popularity of Angioplasty Procedures through Radial Artery
CHD – A Menacing Disease in the UK

Table 46. Number of People Affected with CHD in the UK by Country: 2008-2009 (includes corresponding Graph/Chart)
Table 47. Prevalence of CHD in England by Age Group and Gender (2006) (includes corresponding Graph/Chart)

CHD Related Mortality on the Decline
Product Launch

B. MARKET ANALYTICS

Table 48. The UK Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 49. The UK Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 50. The UK 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

13E.REST OF EUROPE

Market Analysis

Table 51. Rest of European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 52. Rest of European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 53. Rest of European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

14.ASIA-PACIFIC

A. MARKET ANALYSIS

Rising Demand for Angioplasty Devices in China

Table 54. Unit Sales of PTCA Balloon Catheters in China by Type (2005-2009) (includes corresponding Graph/Chart)

Foreign Companies Continue to Dominate Chinese PTCA Balloon Market
CHD in Australia – An Overview of Disease Statistics in the Country
Strong Growth Ahead for IC Devices
Product Launch
Strategic Corporate Development

B. MARKET ANALYTICS

Table 55. Asia-Pacific Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 56. Asia-Pacific Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 57. Asia-Pacific 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

15.LATIN AMERICA

A. MARKET ANALYSIS

Steady Growth Ahead for Latin American IC Devices Market
Brazilian DES Market Suffers Due to Non-Reimbursement Policy in Public Healthcare System

B. MARKET ANALYTICS

Table 58. Latin American Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 59. Latin American Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 60. Latin American 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

16.REST OF WORLD

Market Analysis

Table 61. Rest of World Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 62. Rest of World Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 63. Rest of World 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type – Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

Competitive Landscape
Total Companies Profiled: 34 (including Divisions/Subsidiaries - 38)
Region/CountryPlayers
The United States
Japan
Europe
France
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Skip to top


Japanese Market for Interventional Cardiology 2010 US$ 7,495.00 Mar, 2010 · 231 pages
U.S. Market for Interventional Cardiology Devices 2011 US$ 7,495.00 Dec, 2010 · 311 pages
Cordis Medical Device Company Intelligence Report US$ 340.00 Jul, 2013 · 34 pages

Ask Your Question

Percutaneous Transluminal Coronary Angioplasty (PTCA) Products: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: